Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine Once Daily vs Twice Daily in Schizophrenia
NCT02286206Phase 4Withdrawn
- Sponsor
- University of British Columbia
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, psychotic disorder, sponsored by University of British Columbia. Planned start Jan 2015; status: withdrawn.
02
Drugs
clozapine
03
Conditions
schizophreniapsychotic disorder
Beyond the preview
Go deeper on NCT02286206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286206.